Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis, and it most often affects the lungs. In Bulgaria, the incidence of tuberculosis has decreased from 27,9 cases per 100,000 people in 2011 to 9,7 cases per 100,000 people in 2021. The number of registered cases of tuberculosis varies significantly by region. In Northwestern and Central Bulgaria, the incidence is above the national average. TB spread control should be carried out by conducting specific immunoprophylaxis, providing timely diagnosis and treatment of new patients, reducing poverty, and providing access to health education for the most vulnerable groups.
Barberis I, Bragazzi NL, Galluzzo L, Martini M. The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus. J Prev Med Hyg. 2017;Mar;58(1):E9-E12. PMID: 28515626; PMCID: PMC5432783.
Caño-Muñiz S, Anthony R, Niemann S, Alffenaar JC. New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State. Clin Microbiol Rev. 2017;31(1):e00060-17. Published 2017 Nov 29. doi:10.1128/CMR.00060-17
Chouchkova M. Stefanova, T., Mihaylov, A. 2008: Centenary of the BCG vaccine. //29th Annual Congress, Plovdiv, Bulgaria, 2008, с. 5-9.
Dartois, V.A., Rubin, E.J. Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol (2022). https://doi.org/10.1038
Ehrt S, Schnappinger D. Mycobacterial survival strategies in the phagosome: defence against host stresses. Cell Microbiol. 2009;11:1170–1178.
Kendall EA, Fojo AT, Dowdy DW. Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis. Lancet Respir Med. 2017;5(3):191-199.
Luca S, Mihaescu T. History of BCG Vaccine. Maedica (Bucur) 2013;8(1):53-58.
MacPherson P, Lebina L, Motsomi K, Bosch Z, Milovanovic M, Ratsela A, Lala S,et al. Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial. PLoS One. 2020;15(3):e0230376.
Matsuyama M, Nonaka M, Nakajima M, Morishima Y, Ishii Y, Hizawa N. The Role of NRF2 in Mycobacterial Infection. Antioxidants (Basel). 2021;10(12):1861.
Migliori GB, Sotgiu G, Klintz SR.vERS/ECDC Statement: European Union standards for tuberculosis care. 2017 update Eur Respir J 2018; 51: 1702678.
Migliori GB., Tiberi S, Zumla A, Petersen E, Chakaya JM, Wejse C, et al. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. International Journal of Infectious Diseases. 2020; 92, S15-S25. https://doi.org/10.1016/j.ijid.2020.01.042
Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003;16(3):463-496. doi:10.1128/CMR.16.3.463-496.2003
Zheng YQ, Naguib YW, Dong Y, Shi YC, Bou S, Cui Z. Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy. Expert Rev Vaccines. 2015;14(9):1255-1275.
WHO [Internet]. Tuberculosis Key facts Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis
Министерство на здравеопазването [Internet]. На 24 март отбелязваме Световния ден за борба с туберкулозата Available from: https://www.mh.government.bg/bg/novini/aktualno/na-24-mart-otbelyazvame-svetovniya-den-za-borba-s-/
Министерство на здравеопазването [Internet]. Национална програма за превенция и контрол на туберкулозата в Република България за периода 2021 – 2025 година.
Available from: https://www.mh.government.bg/media/filer_public/2021/08/09/nacionalna-programa-prevenciq-kontrol-tuberkuloza-2021-2025.pdf
Национална мрежа за децата [Internet]. МЗ променя имунизационния календар.
Available from: https://nmd.bg/mz-promenya-imunizatsionniya-kalendar/
